Managing alopecia areata
Familiarity with current therapies will help GPs manage this condition and inform patients of realistic expectations.
Alopecia areata is a chronic inflammatory disorder of the hair follicles that results in non-scarring hair loss.
It is characterised by T-cell-mediated peribulbar inflammation, which induces dystrophic changes in anagen (actively growing) follicles that cause their premature transition to the catagen and telogen (non-proliferative) stages of the hair cycle.1,2
The lifetime risk of developing alopecia areata is approximately 2%, with no sex